Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:01 AM
Ignite Modification Date: 2025-12-25 @ 12:01 AM
NCT ID: NCT03276858
Eligibility Criteria: Inclusion Criteria: * BMI 18 to 30 kg/m2 * Females postmenopausal or surgically sterile Exclusion Criteria: * Any uncontrolled or active major systemic disease including, but not limited to: acromegaly (with or without pituitary surgery or radiation therapy), cardiac, pulmonary, gastrointestinal, metabolic, urogenital, neurological, immunological, psychiatric, or neoplastic disorder with metastatic potential * History or presence of malignancy within the past 5 years. Subjects who have been successfully treated (for 3 months or longer) with no recurrence of basal or squamous cell carcinoma of the skin or carcinoma in-situ of the cervix may be enrolled. * Use of any investigational drug within the past 60 days or 5 half-lives, whichever is longer * Have a medically significant abnormality observed during screening or the admission physical examination or in any other baseline measurements * Use of any prior medication without approval of the investigator within 14 days prior to admission * Tested positive at screening for HIV, hepatitis B surface antigen (HBsAg) or hepatitis C antibody (HCV-Ab) or has a history of a positive result * History of alcohol or substance abuse in the past 6 months * Any condition that in the opinion of the investigator would jeopardize the subject's appropriate participation in this Phase 1 study
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 50 Years
Study: NCT03276858
Study Brief:
Protocol Section: NCT03276858